Role of human cripto-1 in tumor angiogenesis

Tumor Growth Factor Section, Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
CancerSpectrum Knowledge Environment (Impact Factor: 15.16). 02/2005; 97(2):132-41. DOI: 10.1093/jnci/dji011
Source: PubMed

ABSTRACT Human cripto-1 (CR-1) promotes cell transformation and increases migration and invasion of various mouse and human epithelial cell lines. We investigated whether CR-1 also stimulates angiogenesis.
We used human umbilical vein endothelial cells (HUVECs) to measure in vitro migration with fibronectin-coated Boyden chambers, invasion with Matrigel-coated Boyden chambers, proliferation with a tetrazolium salt, and differentiation with an in vitro Matrigel assay. We investigated new blood vessel formation in vivo by use of Matrigel-filled silicone cylinders implanted under the skin of nude mice and by use of a breast cancer xenograft model with CR-1-transfected or control Neo-transfected MCF-7 human breast cancer cells. We also used a blocking anti-CR-1 monoclonal antibody to investigate the role of CR-1 in angiogenesis in vivo and in vitro. All statistical tests were two-sided.
CR-1 stimulated HUVEC proliferation, migration, and invasion and induced HUVEC differentiation into vascular-like structures on Matrigel. In vivo, recombinant CR-1 protein induced microvessel formation in Matrigel-filled silicone cylinders, and microvessel formation was statistically significantly inhibited with a blocking anti-CR-1 monoclonal antibody (CR-1 and antibody = 127% of microvessel formation compared with that in untreated control cylinders and CR-1 alone = 259%; difference = 132%, 95% confidence interval [CI] = 123% to 140%; P<.001). Tumors formed by CR-1-transfected MCF-7 cells in the cleared mammary fat pad of nude mice had higher microvessel density than tumors formed by control Neo-transfected MCF-7 cells (CR-1-transfected cells = 4.66 vessels per field and Neo-transfected cells = 2.33 vessels per field; difference = 2.33 vessels per field, 95% CI = 1.2 to 2.8; P = .004).
CR-1 appears to have an important role in the multistep process of angiogenesis.

Download full-text


Available from: Morihisa Hirota, Jul 01, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cripto-1, a co-receptor for Nodal, can activate Nodal-dependent and Nodal-independent signaling pathways. In this study we have investigated whether Cripto-1 mutants, that fail to activate a Nodal-dependent signaling pathway, are capable to activate a Nodal-independent signaling pathway in mammary epithelial cells. Cripto-1 mutants expressed in EpH4 mouse mammary epithelial cells are fully functional in regard to activation of a Nodal-independent signaling pathway, leading to phosphorylation of mitogen-activated protein kinase (MAPK) and Akt and to enhanced proliferation and motility of these cells, suggesting that Cripto-1 mutants with impaired Nodal signaling are still active in a Nodal-independent signaling pathway.
    FEBS Letters 12/2008; 582(29):3997-4002. DOI:10.1016/j.febslet.2008.10.052 · 3.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The first use of the term angiogenesis was in 1787 by John Hunter, a British surgeon [1]. However, there were very few reports of tumor angiogenesis until almost 100 years later, and these were mainly anatomical studies. For example, the vascular morphology of tumors was studied in considerable detail beginning in the 1860s [2, 3]. By 1907, the vascular network in human and animal tumor specimens was visualized by intraarterial injections of bismuth in oil [4]. The vascular morphology was studied in both human and animal tumors in the first half of the 20th century, mainly to determine if vascular patterns could distinguish benign from malignant tumors, to understand the shedding of tumor emboli into the circulation, or to interpret the delivery of active agents into specific tumors [5–8].
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper reports the emission spectra, pulse heights and decay curves of CsI(Tl) crystals with a Tl* concentration ranging from 10<sup>-6</sup> mol to 10<sup>-2</sup> mol, under electron and alpha particle excitations. Larger pulse heights from the crystals with Tl+concentration of more than 10<sup>-3</sup> mol were observed for a higher ionization density of alpha particle excitation, compared with those of electron excitation. This enhancement may be explained in terms of the higher. Scintillation efficiency for higher Tl* concentration. Decay curves under electron and alpha particle excitations were compared with the decay curve under pulsed UV excitation. The observed decay curves were explained in terms of the sum of the three energy transfer processes to create excited states (Tl<sup>+</sup>)*; the prompt process, the V<sub>k</sub> diffusion process to Tl<sup>0</sup> and the electron release process from Tl<sup>0</sup> to Tl<sup>++</sup>. Here, Tl<sup>0</sup> and Tl<sup>++</sup> were-produced through (Tl<sup>++</sup> electron)→Tl<sup>0</sup> and (Tl<sup>++</sup> hole (or V<sub>k</sub>)) →Tl<sup>++</sup>
    Nuclear Science Symposium Conference Record, 2000 IEEE; 02/2000